Purchase Order 75N94025P00097

Award Date 1/1/25
Potential Completion Date 12/31/25
Potential Value $180K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $180,000.00 firm-fixed price purchase order contract to Exonova Biosciences LLC, a woman-owned small business, for the acquisition of services of a contract inflammatory and vascular diseases scientist. The contract has a period of performance from January 1, 2024 through December 31, 2024. The selected contractor must have over 15 years of specialized experience in areas...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, awarded a $175,089.53 firm-fixed price delivery order to Revolutionary Solutions LLC, a woman-owned small business. The order was placed under Revolutionary Solutions' existing Multiple Award Schedule (MAS) contract with the General Services Administration (GSA) and provides administrative support services to...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Edwan LLC, a minority-owned small disadvantaged business. The $250,000 contract is for the acquisition of services of a Contract Immunology and Hereditary Autoinflammatory Diseases Scientist to support the NIDDK's research initiatives. The contract has a 2-year base period from January 20, 2025 to...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Edwan LLC, a small disadvantaged business, for $108,000.00. The contract is for research and lab support services to support the NIDDK's Biomedical and Metabolic Imaging Branch, with a period of performance from January 20, 2022 to January 19, 2023. The contractor will provide services such...
The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $22,750 firm fixed price purchase order to Dr. Céline Vetter of Almanya. The one-year contract runs from September 4, 2023 through September 3, 2024 to support the agency's research efforts. As the prime contractor, Dr. Vetter will deliver unspecified products or services to NIH/NIDDK to advance their diabetes, digestive, and kidney disease...
This firm-fixed-price purchase order contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Edwan LLC for research and lab support services. The contract has a ceiling value of $103,992.00 and a 12-month period of performance. The work is to be performed at the NIH facility in Germantown, MD and does not have a set-aside designation. The contract supports the NIDDK's Biomedical and Metabolic...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $243,264 firm fixed price purchase order contract to Bioqual, Inc. to provide laboratory analysis services for NIDDK mice studies. The contract, which runs from September 2023 through September 2027 in Potomac, Maryland, was awarded through a solicitation seeking acquisition of such services to support...
The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (HHS-NIH-NIDDK) awarded a $5,295 purchase order to Lifeome Biolabs Inc. of Bethesda, Maryland for the delivery of a custom enzyme-linked immunosorbent assay (ELISA) kit. The firm fixed price contract runs from November 17, 2016 through April 30, 2017 for the requested products and services. No major subcontractors or set aside designations were identified....
The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $25,000 purchase order contract to Build Clinical, LLC of New York, New York. Under the terms of the contract, Build Clinical will provide recruitment services to NIDDK for the period of September 18, 2023 through September 17, 2024. As the lead institute for diabetes, digestive, and kidney research within the Department of Health and Human Services, NIDDK seeks to accelerate...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), awarded a $180,000.00 firm-fixed-price purchase order contract to Exonova Biosciences LLC, a woman-owned small business, for the services of a Contract Inflammatory and Vascular Diseases Scientist. The contract, which has no set-aside designation, requires a PhD-level scientist with over 15 years of specialized experience in immunology or inflammation research to support the Biomedical and Metabolic Imaging Branch's research on exosomes, microRNA, and vascular diseases. The period of performance is one year, from January 1, 2025, to December 31, 2025, with an option for an additional year. The work will be performed at NIH facilities in Bethesda, Maryland.

Generated 12/31/24, 2:14 PM